Parental Attitudes Toward Genetic Testing in Multiple Sclerosis: Insights From a Turkish National Sample
In Genetic testing in multiple sclerosis: Parental attitudes in a Turkish sample, Koç, Beyazit, Bütün Ayhan, Yilmaz, and Terzi address a timely and clinically relevant question: how parents affected by multiple sclerosis (MS), either as patients themselves or as parents of children with MS, view genetic testing. Published in the Journal of Genetic Counseling in January 2026, the study is positioned at the intersection of neurology, genetic counseling, and family decision-making. Its significance lies in the fact that MS is a complex disorder with genetic and environmental contributors, meaning that public and familial perceptions of “genetic risk” may shape reproductive choices, emotional adjustment, and trust in health systems. By focusing on Türkiye, the authors also contribute context-specific evidence from a developing society in which family structures, cultural expectations, and healthcare access may shape responses to genomic medicine in distinctive ways.
Study Design and Sample Characteristics
The study used a questionnaire developed by the researchers and included 326 parents from 52 provinces across Türkiye, giving it an unusually broad geographic reach for a psychosocial survey of this kind. According to the abstract, the participant group consisted of parents diagnosed with MS and parents of children diagnosed with MS, allowing the study to capture attitudes from families who encounter the disease from different generational positions. This is methodologically important because perceptions of genetic testing may differ between those who live with the illness themselves and those who are making sense of it in relation to a child’s diagnosis. Although the abstract does not provide full detail on psychometric development, the sample size and national spread suggest a deliberate effort to obtain a socially varied picture of parental opinion rather than a narrowly local one.
Main Findings: Attitudes Are Socially Patterned
The central finding is that parental attitudes toward genetic testing were not uniform. Instead, they differed significantly by age group, gender, education level, income level, and whether having MS made parenting more difficult, with the reported group differences reaching statistical significance at p < 0.05. This is one of the paper’s strongest contributions: it shows that views on genetic testing are embedded in social position and lived experience rather than being reducible to a simple “for or against” stance. In practical terms, the study suggests that genetic counseling in MS should not assume a single model of parental concern, because attitudes emerge through demographic, economic, and psychosocial circumstances that affect how risk information is interpreted and trusted.
Concerns About Privacy, Security, and Family Conflict
A particularly important result is the clustering of concern around privacy and social consequences. The abstract reports that fathers, participants with lower education and income, and respondents over 51 years of age were more likely to worry about the security and confidentiality of genetic testing. These groups also expressed concern that testing could generate conflict within the family. Scientifically, this finding matters because it expands the discussion beyond technical validity or medical utility and places emphasis on the social risks attached to genetic information. For many families, hesitation about testing may therefore stem less from disbelief in science and more from fear of stigma, misuse of sensitive information, or destabilization of family relationships. That interpretation aligns with broader debates in genetic counseling, where confidentiality and downstream relational effects are often as important as the test result itself.
Family Planning and the Appeal of Genetic Knowledge
In contrast, the study found that mothers and parents with higher levels of education viewed genetic testing more favorably, particularly in relation to family planning. This contrast is revealing because it suggests that genetic testing is not perceived solely as a threat or burden; for some parents, it is also seen as a resource for anticipatory decision-making. From a clinical standpoint, family planning is one of the most ethically sensitive domains in which genetic information is used, especially in conditions such as MS where inheritance is probabilistic rather than deterministic. The article therefore points to a fundamental tension: the same technology may be interpreted either as empowering foresight or as a source of anxiety and interpersonal strain, depending on the respondent’s social and educational context.
Implications for Genetic Counseling and Health Policy
One of the strongest implications of the paper is that genetic counseling for MS in Türkiye should be stratified not only by clinical need but also by psychosocial profile. The authors state that their findings may provide a practical basis for health policy and medical practice, particularly in identifying salient psychosocial dimensions that should be considered when counseling families affected by MS. This means that counseling models should address confidentiality concerns explicitly, explain the limits of genetic prediction in MS with great care, and incorporate family dynamics into pre-test discussions. In health policy terms, the paper supports the need for counseling frameworks that are culturally responsive and attentive to inequalities in education and income, rather than relying on a one-size-fits-all genomic literacy model.
Final Evaluation
Overall, this article makes a valuable contribution because it reframes genetic testing in MS as a social and ethical issue as much as a biomedical one. Its Turkish sample, broad provincial representation, and focus on parental attitudes offer a useful empirical foundation for future work in neurogenetics and counseling practice. At the same time, the abstract indicates that the study is based on questionnaire data, which means the findings are best understood as patterns of opinion rather than direct evidence of behavior in actual testing situations. Even so, the message is clear: acceptance of genetic testing in MS depends not merely on scientific availability, but on trust, perceived benefit, family roles, and social vulnerability. For clinicians, counselors, and policymakers, the paper is a reminder that successful integration of genomic tools requires sensitivity to the human meanings attached to genetic information, especially in family-centered conditions such as MS.
Disclaimer: This blog post is based on the provided research article and is intended for informational purposes only. It is not intended to provide medical advice. Please consult with a healthcare professional for any health concerns.
References:
Kumar, H.R.V., Harsha, V.S., Nadig, K. et al. Investigating the association between rs361525 promotor polymorphism with risk of multiple sclerosis: a meta-analysis. Egypt J Med Hum Genet 26, 124 (2025). https://doi.org/10.1186/s43042-025-00752-1
